Oncostellae

Biotech startup

Startup

SOBRE ONCOSTELLAE

      
Oncostellae is a biotech startup developing small-molecule drugs with innovative scaffolds (NCEs) that modulate clinically validated therapeutic targets in oncology and inflammatory/autoimmune diseases.
The company was founded in 2013 by a team of medicinal chemists and pharmacologists with a common track record in drug discovery who bring together the experience and network of collaborators to develop clinical candidates from their conception until Phase I/II. Further development and commercialization rights will be licensed to consolidated pharmaceutical companies. 
In 2014 Guido Kurz, a seasoned research manager with international trajectory in various pharmaceutical and biotech companies (including Pharmacia Corp. and Oryzon Genomics), joined Oncostellae as CEO of the company.
    
Organization founded in Spain.

INVERSORES(1)

SECTORES - INDUSTRIA

UBICACIONES

COMPARTIR PERFIL

Este perfil tiene una gran apariencia, ¿quieres compatirlo con todos?
PRINCIPIANTE
AVANZADO
PROFESIONAL

NOTICIAS

Noticias añadidas recientemente sobre Oncostellae:
Oncostellae cierra una ronda de 1,8 millones de euros

Esta web usa cookies para que podamos entender cómo se utiliza el sitio. Si sigues navegando asumiremos que te parece bien. Si quieres utilizar este sitio sin cookies o si quieres saber más, puedes hacerlo aquí .